Adams Jerome M. 4
4 · Atea Pharmaceuticals, Inc. · Filed Jun 23, 2026
Research Summary
AI-generated summary of this filing
Atea (AVIR) Director Jerome M. Adams Exercises Options, Receives RSUs
What Happened
- Director Jerome M. Adams reported derivative activity and awards on June 18, 2026. The Form 4 shows an exercise/conversion of 29,600 derivative shares (code M) and the acquisition of two awards totaling 64,400 restricted stock units (26,700 and 37,700 shares) (code A). All transactions were reported at $0 per share on the filing.
Key Details
- Transaction date: June 18, 2026; filing date: June 23, 2026 (appears filed one business day late relative to the two-business-day Form 4 deadline).
- Reported amounts and prices: 29,600 shares exercised/converted (M) at $0; RSU awards of 26,700 and 37,700 shares (A) at $0. No cash amounts are shown on the filing.
- Shares owned after the transactions: not specified in the provided summary — see the full Form 4 for total holdings.
- Footnotes of note:
- F1: Each RSU represents a contingent right to one share of common stock.
- F2: Some RSUs vested in full on June 18, 2026.
- F3: Other RSUs vest in a single installment on the earlier of the next annual meeting after June 18, 2026 or June 18, 2027, subject to continued service.
- F4: The option referenced vests in 12 monthly installments after June 18, 2026 and fully vests June 18, 2027, subject to continued service.
- Transaction codes: M = exercise/conversion of a derivative; A = grant/award.
Context
- These transactions represent awards and derivative activity (vesting/convertibility) rather than open-market purchases or sales. The $0 per-share reporting is typical for grants, vesting RSUs, or certain conversions/net settlements and does not indicate proceeds from a market sale. Because a Form 4 was filed after the two-business-day window, the filing is late by one business day; late filings reduce timely transparency but do not by themselves indicate any trading impropriety.
Insider Transaction Report
Form 4
Adams Jerome M.
Director
Transactions
- Exercise/Conversion
Common Stock
[F1]2026-06-18+29,600→ 92,350 total - Exercise/Conversion
Restricted Stock Units
[F1][F2]2026-06-18−29,600→ 0 total→ Common Stock (29,600 underlying) - Award
Restricted Stock Units
[F1][F3]2026-06-18+26,700→ 26,700 total→ Common Stock (26,700 underlying) - Award
Stock Option (Right to Buy)
[F4]2026-06-18+37,700→ 37,700 totalExercise: $4.36Exp: 2036-06-17→ Common Stock (37,700 underlying)
Footnotes (4)
- [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The RSUs vested in full on June 18, 2026.
- [F3]The RSUs vest in a single installment on the earlier of (i) the date of the next annual meeting of the Issuer's stockholders occurring after June 18, 2026 or (ii) June 18, 2027, in each case, subject to the Reporting Person's continued service through the applicable vesting date.
- [F4]The option vests and becomes exercisable in twelve (12) substantially equal monthly installments following June 18, 2026, such that the option shall be fully vested on June 18, 2027, subject to the Reporting Person's continued service through each such vesting date.
Signature
/s/ Andrea Corcoran, as Attorney-in-Fact for Jerome M. Adams|2026-06-23